Emerging Market Sales Boost Glaxosmithkline; Profit Up 11 Percent

GlaxoSmithKline’s second quarter profit grew by about 11 percent as strong sales in emerging markets offset declining sales in the United States that are being hurt by competition from generic drugs, the pharmaceutical giant reported on Wednesday. (GSK)

Topics:  united states   gsk   sales   glaxosmithkline   profit   percent   emerging market   
BING NEWS:
  • Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
    Recent sales of a little-known stock, Madrigal Pharmaceuticals (NASDAQ: MDGL), could bode well for Novo Nordisk A/S (NYSE: NVO). The pharma industry giant has seen explosive sales growth for its GLP-1 ...
    12/18/2024 - 2:38 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News